Primary Human Papillomavirus Screening for Cervical Cancer in the United States-US Food and Drug Administration Approval, Clinical Trials, and Where We Are Today

    Authors

    R. Nayar; R. A. Goulart; P. G. Tiscornia-Wasserman;D. D. Davey

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    Cancer Cytopathol.

    Keywords

    CONSENSUS GUIDELINES; CYTOLOGY; WOMEN; RISK; PREVENTION; VACCINATION; PREVALENCE; MANAGEMENT; TESTS; AGE; Oncology; Pathology

    Abstract

    The US Food and Drug Administration recently approved the additional indication of Primary Screening for the Roche cobas human papillomavirus test. This commentary includes an overview of the supporting clinical trial data, issues this approval will present for laboratorians, and proposed clinical management guidelines for abnormal screening results.

    Journal Title

    Cancer Cytopathology

    Volume

    122

    Issue/Number

    10

    Publication Date

    1-1-2014

    Document Type

    Editorial Material

    Language

    English

    First Page

    720

    Last Page

    729

    WOS Identifier

    WOS:000343877100004

    ISSN

    1934-662X

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.